#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia recurrent Thalassaemia alpha Endocrine ophthalmopathy Pneumonia Acquired C1 inhibitor deficiency Immunoglobulin G4 related disease Mucopolysaccharidosis II Medulloblastoma recurrent Dementia with Lewy bodies Hodgkin's disease recurrent Hypersomnia Lymphoma Cervix carcinoma Epilepsy PIK3CA related overgrowth spectrum More trials…

    Learn about Rare Diseases

    Familial amyotrophic lateral sclerosis – Basic Information Alternating hemiplegia of childhood – Treatment Mast cell activation syndrome Factor IX deficiency – Treatment Ornithine transcarbamoylase deficiency – Diagnostics Chondrosarcoma metastatic – Basic Information Mantle cell lymphoma refractory – Diagnostics Aicardi-Goutieres syndrome – Treatment Pituitary-dependent Cushing’s syndrome – Life with Disease Hepatic angiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ramipril MZE829 Vemircopan Medroxyprogesterone Acetate Gefitinib Rbl027.2 SAROGLITAZAR HEMIMAGNESIUM Bromocriptine Gns561 Filgrastim Prednisolone Iohexol Alxn1850 Co-Trimoxazole Tazobactam Isoprenaline Hydrochloride Fluoroestradiol F-18 Betula Verrucosa Pollen Ab-729 Corline Heparin Conjugate More therapies…

    Learn about Your Condition

    Testicular leiomyosarcoma Peritoneal abscess Anal fistula Skin cancer H1N1 influenza Round cell liposarcoma Stress cardiomyopathy Acute leukaemia Cutaneous sarcoidosis Poor quality sleep Glomerulonephritis chronic Dyslipidaemia Oropharyngeal cancer Substance use disorder Peptostreptococcus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Synovitis

  • Efficacy of efanesoctocog alfa in reducing synovitis in patients with congenital hemophilia A – a multicenter, randomized, open‑label phase 3 trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Synovitis
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Austria Germany
  • Study of intra-articular liraglutide (4P004) for patients with knee synovitis and osteoarthritis

    Not recruiting

    2 1
    Investigated Drugs:
    • Liraglutide
    Denmark France Poland Spain
  • Study on the Safety and Effects of AMB-05X Injections for Patients with Tenosynovial Giant Cell Tumor

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Synovitis
    Investigated Drugs:
    • Amb-05X
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!